Your browser doesn't support javascript.
loading
Immunotherapeutic Potential of Oncolytic H-1 Parvovirus: Hints of Glioblastoma Microenvironment Conversion towards Immunogenicity.
Angelova, Assia L; Barf, Milena; Geletneky, Karsten; Unterberg, Andreas; Rommelaere, Jean.
Affiliation
  • Angelova AL; Department of Tumor Virology (F010), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. a.angelova@dkfz-heidelberg.de.
  • Barf M; Department of Tumor Virology (F010), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. m.barf@dkfz-heidelberg.de.
  • Geletneky K; Department of Neurosurgery, University Hospital, 69120 Heidelberg, Germany. karsten.geletneky@mail.klinikum-darmstadt.de.
  • Unterberg A; Department of Neurosurgery, University Hospital, 69120 Heidelberg, Germany. andreas.unterberg@med.uni-heidelberg.de.
  • Rommelaere J; Department of Tumor Virology (F010), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. j.rommelaere@dkfz-heidelberg.de.
Viruses ; 9(12)2017 12 15.
Article in En | MEDLINE | ID: mdl-29244745

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes, Cytotoxic / Microglia / Glioblastoma / Oncolytic Viruses / Oncolytic Virotherapy / H-1 parvovirus / Immunologic Factors Type of study: Prognostic_studies Limits: Humans Language: En Journal: Viruses Year: 2017 Document type: Article Affiliation country: Germany Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes, Cytotoxic / Microglia / Glioblastoma / Oncolytic Viruses / Oncolytic Virotherapy / H-1 parvovirus / Immunologic Factors Type of study: Prognostic_studies Limits: Humans Language: En Journal: Viruses Year: 2017 Document type: Article Affiliation country: Germany Country of publication: Switzerland